Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: NEUROHOPE THERAPEUTICS, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-01-27 to 2025-09-02
Current total value of award: $249487.42
Description: PHASE I PROJECT TITLED, DEXAMETHASONE NANOTHERAPEUTICS FOR TRAUMATIC BRAIN INJURY